[ Price : $8.95]
FDA warns Alsip, IL-based GC America about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA extends its review of an AstraZeneca NDA for camizestrant, an experimental breast cancer therapy, after requesting additional ...[ Price : $8.95]
Corcept Therapeutics plans to resubmit its NDA for relacorilant as a treatment for patients with Cushings syndrome, following addi...[ Price : $8.95]
FDA approves an AbbVie NDA for Decnupaz (pivekimab sunirine-pvzy) and its use in treating adults with blastic plasmacytoid dendrit...[ Price : $8.95]
NSF consultants report on a webinar discussing the best practices in responding to inspection observations in a form FDA-483.[ Price : $8.95]
FDA warns Springfield, MA-based physician Adnan Dahdul about Bioresearch Monitoring violations in his conduct of a clinical invest...[ Price : $8.95]
FDA extends by 30 days the comment period on a request for information entitled AI-Enabled Optimization of Early-Phase Clinical Tr...[ Price : $8.95]
Eli Lilly says it is acquiring three vaccine developers in deals worth up to $3.8 billion combined, expanding its push into infect...